Search

Your search keyword '"Gonzalez-Galvez, G"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Gonzalez-Galvez, G" Remove constraint Author: "Gonzalez-Galvez, G"
22 results on '"Gonzalez-Galvez, G"'

Search Results

1. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

2. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

3. Glycemic Control and Prevention of Diabetic Complications in Low- and Middle-Income Countries: An Expert Opinion

4. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

7. Evolocumab and clinical outcomes in patients with cardiovascular disease

8. Evolocumab and clinical outcomes in patients with cardiovascular disease

9. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

10. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

11. Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

16. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A(1)chieve study.

17. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

18. Glycemic Control and Prevention of Diabetic Complications in Low- and Middle-Income Countries: An Expert Opinion.

19. Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial.

20. VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES: PREVALENCE AND COMORBIDITIES IN 6 COUNTRIES OF LATIN AMERICA (A COHORT OF THE DISCOVER STUDY PROGRAM).

21. Type 2 diabetes mellitus management and body mass index: experiences with initiating insulin detemir in the a1chieve study.

22. Safety and effectiveness of insulin detemir in different age-groups in the a1chieve study.

Catalog

Books, media, physical & digital resources